- Home
- PMI vs RNAC Comparison
PMI vs RNAC Comparison
Compare PMI & RNAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PMI | RNAC |
|---|---|---|
| Founded | 1981 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 202.7M | 175.8M |
| IPO Year | 2025 | 2016 |
Fundamental Metrics
Financial Performance| Metric | PMI | RNAC |
|---|---|---|
| Price | $1.73 | $6.75 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $38.40 |
| AVG Volume (30 Days) | ★ 2.6M | 253.2K |
| Earning Date | 11-14-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $4,767,000.00 | $1,091,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 8.81 | N/A |
| 52 Week Low | $1.65 | $5.98 |
| 52 Week High | $13.68 | $20.12 |
Technical Indicators
Market Signals| Indicator | PMI | RNAC |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.33 |
| Support Level | N/A | $6.40 |
| Resistance Level | N/A | $6.88 |
| Average True Range (ATR) | 0.00 | 0.60 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 0.00 | 11.66 |
Price Performance
Historical ComparisonAbout PMI Picard Medical Inc.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.
About RNAC Cartesian Therapeutics Inc.
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company. The company uses its ImmTOR immune tolerance platform, which is designed to give rise to antigen-specific immunity, mitigating unwanted immune responses. The company leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function.